Evidence map›Paper›PMID 31862013›Full record

ArticleGenome medicine2019

Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation.

Hannah Gelman, Jennifer N Dines, Jonathan Berg, Alice H Berger, Sarah Brnich, Fuki M Hisama, Richard G James, Alan F Rubin, Jay Shendure, Brian Shirts and 3 more

Abstract read
In one paragraph

Article in Genome medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. MAVISp: A modular structure-based framework for protein variant effects.Protein science : a publication of the Protein Society · 2026
    Article
  5. Review
  6. Genetic analysis of neurodegenerative diseases.The Journal of clinical investigation · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Mastering genetics for your clinic: A step-by-step guide.The Journal of allergy and clinical immunology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Functional assays inGenome research · 2025
    Review
  16. Article
  17. Functional analysis ofGenetics in medicine open · 2025
    Article
  18. Article
  19. A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hannah GelmanDepartment of Genome Sciences, University of Washington School of Medicine, 15th Avenue NE, Seattle, WA, 98195, USA.
Jennifer N DinesDepartment of Genome Sciences, University of Washington School of Medicine, 15th Avenue NE, Seattle, WA, 98195, USA.
Jonathan BergDepartment of Genetics, University of North Carolina at Chapel Hill,, Mason Farm Road, Chapel Hill, NC, 27514, USA.
Alice H BergerHuman Biology Division, Fred Hutchinson Cancer Research Center, Fairview Avenue, Seattle, WA, 98109, USA.
Sarah BrnichDepartment of Genetics, University of North Carolina at Chapel Hill,, Mason Farm Road, Chapel Hill, NC, 27514, USA.
Fuki M HisamaDivision of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Richard G JamesBrotman Baty Institute for Precision Medicine, NE Pacific Street, Seattle, WA, 98195, USA.
Alan F RubinBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Royal Parade, Parkville, VIC, 3052, Australia.
Jay ShendureDepartment of Genome Sciences, University of Washington School of Medicine, 15th Avenue NE, Seattle, WA, 98195, USA.
Brian ShirtsBrotman Baty Institute for Precision Medicine, NE Pacific Street, Seattle, WA, 98195, USA.
Douglas M FowlerDepartment of Genome Sciences, University of Washington School of Medicine, 15th Avenue NE, Seattle, WA, 98195, USA. dfowler@uw.edu.
Lea M StaritaDepartment of Genome Sciences, University of Washington School of Medicine, 15th Avenue NE, Seattle, WA, 98195, USA. lstarita@uw.edu.ORCID 0000-0003-2870-5099
Brotman Baty Institute Mutational Scanning Working Group

Funding

Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
NHGRI NIH HHS HG010461NHGRI NIH HHS RM1 HG010461NIGMS NIH HHS T32 GM007092
6 · The paper itself

Abstract

Variants of uncertain significance represent a massive challenge to medical genetics. Multiplexed functional assays, in which the functional effects of thousands of genomic variants are assessed simultaneously, are increasingly generating data that can be used as additional evidence for or against variant pathogenicity. Such assays have the potential to resolve variants of uncertain significance, thereby increasing the clinical utility of genomic testing. Existing standards from the American College of Medical Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) and new guidelines from the Clinical Genome Resource (ClinGen) establish the role of functional data in variant interpretation, but do not address the specific challenges or advantages of using functional data derived from multiplexed assays. Here, we build on these existing guidelines to provide recommendations to experimentalists for the production and reporting of multiplexed functional data and to clinicians for the evaluation and use of such data. By following these recommendations, experimentalists can produce transparent, complete, and well-validated datasets that are primed for clinical uptake. Our recommendations to clinicians and diagnostic labs on how to evaluate the quality of multiplexed functional datasets, and how different datasets could be incorporated into the ACMG/AMP variant-interpretation framework, will hopefully clarify whether and how such data should be used. The recommendations that we provide are designed to enhance the quality and utility of multiplexed functional data, and to promote their judicious use.

Indexed as

Genetic VariationGene LibraryGenetic TestingGuidelines as TopicHumansPrecision MedicineQuality ControlSequence Analysis, DNASocieties, Medical

Identifiers

PMID31862013
PMCPMC6925490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.